Financhill
Sell
43

BCYC Quote, Financials, Valuation and Earnings

Last price:
$6.99
Seasonality move :
2.4%
Day range:
$6.90 - $7.28
52-week range:
$6.03 - $15.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.94x
P/B ratio:
1.08x
Volume:
314.6K
Avg. volume:
296.5K
1-year change:
-51.02%
Market cap:
$480.7M
Revenue:
$35.3M
EPS (TTM):
-$3.63

Earnings Data

Next earnings date for BCYC
Feb 24
2026
Most recent earnings per share
-$0.85
Beat by $0.22
(Oct 30/2025)
Consensus Estimate
-$1.07
(Oct 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BCYC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/24/2026 Q4 $7.1M -- -- -$0.94 --
10/30/2025 Q3 $8.2M $11.7M -$0.85 -$1.07 $0.22
08/08/2025 Q2 $9.4M $3M -$1.15 -$0.93 -$0.22
05/01/2025 Q1 $8.7M $10M -$0.88 -$0.81 -$0.07
02/25/2025 Q4 $5.5M $3.7M -$0.74 -$0.85 $0.11
10/31/2024 Q3 $7M $2.7M -$0.75 -$0.78 $0.03
08/06/2024 Q2 $6.3M $9.4M -$0.77 -$1.11 $0.34
05/02/2024 Q1 $6.1M $19.5M -$0.62 -$1.21 $0.59
02/20/2024 Q4 $7M $5.3M -$1.16 -$1.19 $0.03
11/02/2023 Q3 -- -- -$1.26 -$1.06 -$0.20
08/03/2023 Q2 -- -- -$1.41 -$1.07 -$0.34
05/04/2023 Q1 -- -- -$1.30 -$0.96 -$0.34
02/28/2023 Q4 -- -- -$1.01 -$1.04 $0.03
11/03/2022 Q3 -- -- -$0.96 -$0.91 -$0.05
08/04/2022 Q2 -- -- -$0.90 -$0.81 -$0.09
05/05/2022 Q1 -- -- -$0.93 -$0.73 -$0.21
03/01/2022 Q4 -- -- -$0.63 -$0.59 -$0.04
11/04/2021 Q3 -- -- -$0.59 -$0.63 $0.04
08/05/2021 Q2 -- -- -$0.74 -$0.67 -$0.07
05/06/2021 Q1 -- -- -$0.73 -$0.71 -$0.02
03/11/2021 Q4 -- -- -$0.83 -$0.41 -$0.42
11/05/2020 Q3 -- -- -$0.52 -$0.53 $0.01
08/05/2020 Q2 -- -- -$0.67 -$0.46 -$0.21
05/07/2020 Q1 -- -- -$0.63 -$0.38 -$0.25
03/10/2020 Q4 -- -- -$0.25 -$0.52 $0.27
11/07/2019 Q3 -- -- -$0.53 -$0.70 $0.17
08/08/2019 Q2 -- -- -$1.40 -$0.62 -$0.78
03/31/2019 Q1 -- -- -$0.37 -- --
12/31/2018 Q4 -- -- -$0.50 -- --
09/30/2018 Q3 -- -- -$0.58 -- --
06/30/2018 Q2 -- -- -$0.37 -- --
03/31/2018 Q1 -- -- -$0.19 -- --

Bicycle Therapeutics Plc Earnings Questions

  • How Much did Bicycle Therapeutics Plc Generate in Revenue Last Quarter?

    Bicycle Therapeutics Plc reported $11.7M worth of top line sales in its most recent quarter.

  • Did Bicycle Therapeutics Plc Beat Earnings Last Quarter?

    Bicycle Therapeutics Plc announced earnings per share of -$0.85 which represents a beat of analyst forecast a -$1.07 per share.

  • Is Bicycle Therapeutics Plc Profitable?

    Bicycle Therapeutics Plc reported $9.9M that represents $0.14 per share over the last quarter.

  • What is the Analyst Consensus for Bicycle Therapeutics Plc EPS Next Year?

    Bicycle Therapeutics Plc's earnings are forecast to decrease from -$2.91 per share to -$3.05 per share next year representing a decrease of -33.36%.

  • When is Bicycle Therapeutics Plc's Earnings Date?

    Bicycle Therapeutics Plc's next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock